Fucoidan alleviates high-fat diet-induced dyslipidemia and atherosclerosis in ApoEshl mice deficient in apolipoprotein E expression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fucoidan alleviates high-fat diet-induced dyslipidemia and atherosclerosis in ApoEshl mice deficient in apolipoprotein E expression

Published:2016-06 Issue: Volume:32 Page:46-54
ISSN:0955-2863
Container-title:The Journal of Nutritional Biochemistry
language:en
Short-container-title:The Journal of Nutritional Biochemistry

Author:

Yokota Takashi,Nomura Koichi,Nagashima Mikio,Kamimura Naomi

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Nutrition and Dietetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference48 articles.

1. Atherosclerosis. The road ahead;Glass;Cell,2001

2. Single risk factor intervention may be inadequate to inhibit atherosclerosis progression when hypertension and hypercholesterolemia coexist;Chobanian;Hypertension,1991

3. Effect of antioxidant capacity on blood lipid metabolism and lipoprotein lipase activity of rats fed a high-fat diet;Yang;Nutrition,2006

4. Lipoprotein lipase: a key enzyme of lipid metabolism;Bruckert;Rev Prat,1994

5. Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia;Kuusi;J Lipid Res,1989

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of fucoidan in central nervous system disorders: A systematic review;International Journal of Biological Macromolecules;2024-10

2. The influence of processing technologies on the biological activity of carbohydrates in food;Food Chemistry: X;2024-10

3. Fucoidan improving spinal cord injury recovery: Modulating microenvironment and promoting remyelination;CNS Neuroscience & Therapeutics;2024-08

4. The impact of a western diet on gut microbiota and circadian rhythm: A comprehensive systematic review of in vivo preclinical evidence;Life Sciences;2024-07

5. Marine Compounds and Age-Related Diseases: The Path from Pre-Clinical Research to Approved Drugs for the Treatment of Cardiovascular Diseases and Diabetes;Marine Drugs;2024-05-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3